USANA Health Sciences, Inc.USNANYSE
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -6.16% | -3.38% | +9.54% | +10.79% | +6.72% |
| Gross Profit Growth | -6.07% | -2.72% | +3.96% | +5.45% | -0.29% |
| EBITDA Growth | -5.90% | -48.01% | -15.05% | +21.82% | -52.88% |
| Operating Income Growth | -11.39% | -66.10% | -36.49% | -6.29% | -92.15% |
| Net Income Growth | -6.52% | -73.26% | -43.15% | -7.45% | -161.49% |
| EPS Growth | -5.08% | -73.86% | -43.02% | -5.45% | -164.29% |
| EPS Diluted Growth | -5.08% | -73.56% | -43.02% | -3.70% | -164.29% |
| Weighted Average Shares Growth | -0.87% | -0.35% | -0.65% | -2.94% | -4.11% |
| Weighted Average Shares Diluted Growth | -1.49% | -0.77% | -1.12% | -3.25% | -4.14% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +32.83% | -77.77% | -12.45% | +52.92% | -106.64% |
| Free Cash Flow Growth | +30.58% | -78.70% | -12.45% | +35.19% | -119.01% |
| Receivables Growth | +0.00% | +14.19% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +6.50% | +13.48% | +20.84% | +34.67% | +41.88% |
| Asset Growth | +11.67% | +18.24% | +18.64% | +16.33% | +8.24% |
| Book Value per Share Growth | +14.32% | +7.39% | +6.65% | +6.82% | +3.31% |
| Debt Growth | +0.00% | +196.89% | +1642.42% | +0.00% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -5.44% | +7.40% | +10.31% | +6.84% | +9.82% |